Sec Form 4 Filing - Imhoff John E @ GUIDED THERAPEUTICS INC - 2025-03-06-05:00

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Imhoff John E 2. Issuer Name and Ticker or Trading Symbol GUIDED THERAPEUTICS INC [ GTHP] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 5853 PEACHTREE CORNERS EAST, SUITE B 3. Date of Earliest Transaction (MM/DD/YY) 03/06-05:00/2025 (Street) PEACHTREE CORNERS, GA30092 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Preferred Series D Stock 03/06-05:00/2025 J( 1 ) 300 D 0 D Common Stock 03/06-05:00/2025 J( 1 ) 900,000 A 9,662,756 D Preferred Series C2 Stock 03/06-05:00/2025 J( 2 ) 2,400.75 D 0 D Common Stock 03/06-05:00/2025 J( 2 ) 4,801,500 A $ 0.5 14,464,256 D Preferred Series C Stock 03/07-05:00/2025 P( 3 ) 286 A 286 D Preferred Series C Stock 03/11-05:00/2025 J( 3 ) 286 D 0 D Common Stock 03/11-05:00/2025 J( 3 ) 2,258,690 A $ 0.1266 16,722,946 D Common Stock 03/18-05:00/2025 P( 4 ) 1,000,000 A $ 0.1 17,722,946 D Common Stock 03/18-05:00/2025 P( 5 ) 263,069 A $ 0.1 17,986,015 D Common Stock 04/10-05:00/2025 J( 6 ) 6,365 A 17,992,380 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Warrants $ 0.13 03/18-05:00/2025 P( 4 ) 1,000,000 03/18-05:00/2025 03/17-05:00/2029 Common Stock 1,000,000 ( 4 ) 1,000,000 D Warrants $ 0.13 03/18-05:00/2025 P( 5 ) 263,069 03/18-05:00/2025 03/17-05:00/2029 Common Stock 263,069 ( 5 ) 1,263,069 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Imhoff John E 5853 PEACHTREE CORNERS EAST SUITE B PEACHTREE CORNERS, GA30092 X X Signatures /s/ John E. Imhoff 04/17-05:00/2025 Signature of Reporting Person Date

Explanation of Responses:

( 1 )On March 6, 2025, Mr. Imhoff converted 300 shares of Series D preferred stock into 900,000 shares of common stock. The Series D preferred stock had a stated value of $750 and $0.25 exercise price. ( 2 )On March 6, 2025, Mr. Imhoff signed an exchange agreement to convert shares of Series C2 preferred stock at $0.50 conversion prices. For 2,400.75 Series C2 preferred shares, Mr. Imhoff received 4,801,500 common shares. ( 3 )On March 7, 2025, for a purchase price of $112,934.50, Mr. Imhoff purchased 286 shares of Series C preferred stock from a third party. The shares had a conversion price of $0.1266, and on March 11, 2025 were converted to 2,258,690 common shares. ( 4 )On March 18, 2025, the Company entered into a Securities Purchase Agreement (the "March Purchase Agreement") with Dr. Imhoff, pursuant to which the Company agreed to sell, for a total price of $100,000, 1,000,000 units, each unit consisting of one share of common stock and one warrant to purchase up to 1,000,000 shares of common stock (the "March Warrants"). The March Warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.13 per share. ( 5 )In connection with the March Purchase Agreement, the Company entered into an exchange agreement with Dr. Imhoff, whereby Dr. Imhoff agreed to exchange a $25,000 note payable and accrued interest of $1,307 for 263,069 units as described above. ( 6 )These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.0943.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.